Literature DB >> 13710745

The relations between the antinuclear, rheumatoid and L.E.-cell factors in the systemic rheumatic diseases.

A P HALL, W A BARDAWIL, T B BAYLES, A D MEDNIS, N GALINS.   

Abstract

Entities:  

Keywords:  ARTHRITIS, RHEUMATOID/blood; LUPUS ERYTHEMATOSUS/blood; RHEUMATISM/blood

Mesh：

Year:  1960        PMID： 13710745     DOI： 10.1056/NEJM196010202631601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  IMMUNOFLUORESCENT STUDIES ON THE OCCURRENCE OF ANTINUCLEAR FACTOR IN NORMAL HUMAN SERUM.

Authors:  R J LAFFIN; W A BARDAWIL; W N PACHAS; J S MCCARTHY
Journal:  Am J Pathol       Date:  1964-09       Impact factor: 4.307

2.  ANTINUCLEAR FACTOR IN RHEUMATOID ARTHRITIS, ITS INCIDENCE AND CLINICAL SIGNIFICANCE.

Authors:  D J WARD; G D JOHNSON; E J HOLBOROW
Journal:  Ann Rheum Dis       Date:  1964-07       Impact factor: 19.103

3.  GAMMA-2, GAMMA-1A AND GAMMA-1M ANTINUCLEAR FACTORS IN HUMAN SERA.

Authors:  E V BARNETT; J J CONDEMI; J P LEDDY; J H VAUGHAN
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

4.  Lupus erythematosus cells in systemic sclerosis.

Authors:  N R ROWELL
Journal:  Ann Rheum Dis       Date:  1962-03       Impact factor: 19.103

5.  Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis.

Authors:  D D McGavin; J Williamson; J V Forrester; W S Foulds; W W Buchanan; W C Dick; P Lee; R N MacSween; K Whaley
Journal:  Br J Ophthalmol       Date:  1976-03       Impact factor: 4.638

6.  Antinuclear factor in rheumatoid arthritis and related diseases.

Authors:  D A Pitkeathly; G Taylor
Journal:  Ann Rheum Dis       Date:  1967-01       Impact factor: 19.103

7.  [On the problem of immunobiologic relations between lupus erythematosus disseminatus and progressive scleroderma].

Authors:  H Talke; H Holzmann
Journal:  Arch Klin Exp Dermatol       Date:  1967

8.  [Studies on the importance of the fluorescence-antiglobulin test and the antiglobulin-consumption test for the demonstration of antinuclear serum factors].

Authors:  C Mueller-Eckhardt; K Schmidt; W Becker
Journal:  Blut       Date:  1968-07

9.  A clinico-immunological study of serum and synovial fluid antinuclear factors in rheumatoid arthritis and other arthritides.

Authors:  R N MacSween; T G Dalakos; M K Jasani; J A Boyle; W W Buchanan; R B Goudie
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

10.  Malignant melanoma and dermatomyositis.

Authors:  A Katz; J W Digby
Journal:  Can Med Assoc J       Date:  1965-12-25       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.